Status:

TERMINATED

Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma

Lead Sponsor:

Boneca Corporation

Conditions:

Glioblastoma

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

PHASE2

Brief Summary

Boron Neutron Capture Therapy (BNCT) is an experimental radiation therapy technique that is based on the principle of irradiating boron atoms with neutrons. When neutrons have relatively low energy, b...

Detailed Description

This is a single BNCT-facility, non-randomized, non-comparative, prospective, open-label, phase I/II trial to determine the value of BNCT in the treatment of subjects who have undergone surgery for gl...

Eligibility Criteria

Inclusion

  • Histologically confirmed glioblastoma multiforme
  • Supratentorial location
  • At least 30% of the tumor volume has been removed at craniotomy as judged from a pre/perioperative MRI
  • Ability to understand the concept of investigational therapy
  • Tolerates dexamethasone treatment
  • Adequate anti-epileptic medication
  • BNCT can be delivered within 6 weeks from the date of brain surgery
  • A written informed consent

Exclusion

  • Age less than 18 or greater than 75
  • The tumor infiltrates into the optic chiasm or into the deep parts of the brain prohibiting delivery of an adequate radiation dose with BNCT
  • Prior radiation therapy to the brain
  • Prior chemotherapy, immunotherapy, or gene therapy
  • Karnofsky performance score \<70
  • Severe cardiac, liver, or kidney failure
  • Severe infection
  • A cardiac pace-maker, or a metal implant in the head and neck region that will prohibit MRI examination
  • Pregnancy or lactation
  • Phenylketonuria

Key Trial Info

Start Date :

May 1 1999

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2008

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00115453

Start Date

May 1 1999

End Date

August 1 2008

Last Update

August 18 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Oncology, Helsinki University Central Hospital

Helsinki, Finland, FIN-00029